Skip to content
Therapy But Better – Lifestyle
Author:
AdJane
AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans
July 1, 2026
AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans
June 30, 2026
CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea
April 29, 2026